Avanafil Tablet
Product Images NDC 31722-441

10 FDA label images from Camber Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Avanafil (NDC 31722-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Avanafil-structure (Avanafil Structure)

Avanafil-structure (Avanafil Structure)
Chemical structure diagram of Avanafil, illustrating the molecular framework of the active ingredient used in the oral tablet dosage form manufactured by Camber Pharmaceuticals, Inc.*
FDA Label Image

Avanafil-figure (Avanafil Figure)

FDA Label Image

Avanafil-figure-2 (Avanafil Figure 2)

FDA Label Image

Avanafil-figure-3 (Avanafil Figure 3)

FDA Label Image

Avanafil-figure-4 (Avanafil Figure 4)

FDA Label Image

Avanafil-camber-logo-1 (Avanafil Camber Logo 1)

FDA Label Image

Avanafil-camber-logo-2 (Avanafil Camber Logo 2)

FDA Label Image

Avanafil-container-50mg-30s (Avanafil Container 50mg 30s)

FDA Label Image

Avanafil-container-100mg-30s (Avanafil Container 100mg 30s)

FDA Label Image

Avanafil-container-200mg-30s (Avanafil Container 200mg 30s)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.